Related Experiment Video
Updated: Jun 8, 2025

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Challenges in managing severe homozygous protein c deficiency: a case report
Eman Almatter1, Sondus Alsharidah, Mona Bourhama
1Department of Hematology, NBK Specialized Children's Hospital, Kuwait, Kuwait.
Insights
Severe protein C deficiency poses significant thrombosis risks, complicating management even with current therapies. This case underscores the need for improved treatments for this rare genetic disorder.
Area of Science:
- Hematology
- Genetics
- Internal Medicine
Background:
- Protein C deficiency is a rare autosomal recessive disorder.
- It is associated with a high risk of thromboembolic complications.
Observation:
- This case report details the management of a 23-year-old woman with severe homozygous protein C type 1 deficiency.
- Her history included misdiagnosed cellulitis, recurrent thrombosis, and vision loss.
Findings:
- Laboratory workup confirmed severe protein C deficiency.
- Management utilized fresh frozen plasma (FFP), protein C concentrate, warfarin, and heparin.
- Challenges included recurrent thrombosis and anaphylaxis to FFP.
Implications:
- This case highlights diagnostic and management challenges in severe protein C deficiency.
- Current treatments offer partial control, necessitating further research for safer, more effective therapies.
- Improved long-term outcomes require the development of novel therapeutic strategies.
Abstract:
Protein C deficiency is a rare autosomal recessive disorder associated with a high risk of thromboembolic complications. This case report describes the challenges in managing a 23-year-old woman with severe homozygous protein C type 1 deficiency diagnosed since early infancy. Her medical history included misdiagnosed cellulitis, recurrent thrombosis, and permanent vision loss in one eye. The laboratory workup confirmed a diagnosis of severe protein C deficiency. Management involved a combination of fresh frozen plasma (FFP), protein C concentrate, warfarin, and heparin, with ongoing challenges due to recurrent thrombosis and anaphylaxis to FFP. This case highlights the challenges in the diagnosis and management of severe protein C deficiency. Although current treatment options provide partial control, further research is crucial to develop safer and more effective therapies to improve long-term outcomes for affected patients.
More Related Videos
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Multiple Allele Traits
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Inborn Errors of Metabolism
Lysosomal Hydrolases

